{"id":"https://genegraph.clinicalgenome.org/r/999c6525-fef3-4743-b8c3-6230b41982fbv1.2","type":"EvidenceStrengthAssertion","dc:description":"KCNE1 encodes the beta-subunit of voltage-gated potassium channels and is thought to assemble with KCNQ1/KVLQT1 to form Iks (the slowly activating delayed rectifier cardiac potassium channel). There is strong evidence associating KCNE1 with acquired LQTS, however, only limited evidence for its association with unprovoked LQTS. Furthermore, several case reports have identified homozygous or compound heterozygous rare variants in KCNE1 in patients with Jervell-Lange-Nielsen Syndrome, however parents or siblings carrying only one allele have reported normal phenotypes suggesting an association of this gene with an autosomal-recessive form of LQTS (PMIDs 9354783, 9328483, 9445165).\nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132‚Äù","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/999c6525-fef3-4743-b8c3-6230b41982fb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-15T00:21:42.973Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2021-01-14T21:14:59.621Z","role":"Publisher"}],"curationReasonDescription":"See evidence summary","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6a582c4-c161-4f44-be92-615d91c686a9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29bed73d-27e1-4e9a-80a1-3b858fe7e553","type":"Finding","dc:description":"C-terminus of KCNE1 directly interacts with the pore region of Kv7.1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9201970","rdfs:label":"KCNE1 directly interacts with KCNQ1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/976284a3-0b6c-41c9-8916-fd60447573f9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcafc136-7e61-48fb-9484-f7883ec0b2c8","type":"Finding","dc:description":"Physical interaction between C-termini of Kv7.1 and KCNE1: when expressed in cultured cells, the KCNE1-C terminus co-localized with KCNQ1, co-immunoprecipitated with KCNQ1 and perturbed deactivation kinetics of the KCNQ1 currents.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20196769","rdfs:label":"Physical interaction between C-termini of Kv7.1 and KCNE1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/801bcad9-f2ac-4a7d-8a49-379441c05297","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b88d2ce0-1a9e-4305-a49a-352e871eb0dc","type":"Finding","dc:description":"Disruption of the K+ channel would cause cardiac arrhythmia","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1939241","rdfs:label":"In vitro mutagenesis and patch clamp voltage experiments","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3d8f30b-e91e-4838-8494-b11d97efc9d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a3d88d9-ae1e-4076-a608-7855fb54c055","type":"FunctionalAlteration","dc:description":"The mutant G52R-KCNE1 significantly reduced Iks current amplitudes (6.362.9 mA at 160 mV; n59, P<0.05 versus KCNQ1/WT-KCNE1).\nThe mutant G52R-KCNE1 has a dominant negative effect on Iks current amplitude which could lead to a prolongation of the cardiac action potential and QT interval prolongation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14499862","rdfs:label":"voltage clamp analysis"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e3f35bb5-ed18-404e-9f28-c2521bb79412","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e747d60c-2c99-4666-9e88-79fecb25468d","type":"FunctionalAlteration","dc:description":"The variant causes a dominant effect of shifting the voltage dependence of KCNQ1 activation in positive direction, in both cell systems. KCNQ1 trafficking is not affected. Other variants at the same amino acid (Y81T and T81F) have similar effect.  The variant also makes the channel more sensitive to IKS suppressors (azimilide), and potentiates the activity of IKS activators (fenamate and stilbene)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16945797","rdfs:label":"Eletrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fe15553b-3550-456c-8caf-f5ed0e80b193","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/548a11f8-4d6f-4758-b260-2dff2f0f48ba","type":"FunctionalAlteration","dc:description":"Patch clamp voltage experiments in Xenopus oocytes were done and showed that co-injection of either mutant allele of KCNE1, along with wildtype KCNE1 and KCNQ1 (to mimic the heterozygous situation) resulted in reduction of the IKS by shifting voltage dependence of activation and accelerating channel deactivation.  This would be hypothesized to result in delayed repolarization of the cardiac cells. D76N had a strong dominant negative effect, reducing the current by 91% in the presence of wildtype KCNE1 and KCNQ1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","rdfs:label":"Patch clamp experimentation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1247e0f3-4d6e-45d7-aef1-f6e895692e12","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/026ded07-fb95-4d3d-bb14-f41d0639e343","type":"FunctionalAlteration","dc:description":"co-transfection of the Arg36His KCNE1 variant together with wildtype KCNE1 and KCNQ1 resulted in a reduction of the inward rectifying K+ current relative to transfection of only wildtype KCNE1 with KCNQ1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29625280","rdfs:label":"Patch clamp"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/de1fff92-2766-4e12-9b1e-315d97e58da4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b7af8ff-e1a2-48b2-9eee-b9dab90cffbc","type":"FunctionalAlteration","dc:description":"G52R and T58P/L59P produce currents that lack the kinetic behavior of IKs. In contrast,\nS74L and R98W both produce IKs-like currents but with rightward shifted voltage dependence of activation. All of the LQT5 mutants express protein robustly, and T58P/L59P and R98W cause modest, but significant, defects in the trafficking of KCNQ1. Despite defects in trafficking, in the presence of KCNQ1, T58P/L59P and the other\nLQT5 mutants are present at the plasma membrane. Interestingly, in comparison to KCNE1 and the other LQT5 mutants, T58P/L59P associates only weakly with KCNQ1.T58P/L59P causes disease through a novel mechanism that involves defective IKs\ncomplex assembly.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19907016","rdfs:label":"electrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ae9c532-4a9e-48db-9bd0-c2f64e09d4d7","type":"EvidenceLine","dc:description":"Not clear if this really represents a true heterozygous mimic","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/458545c3-9e14-4568-8e64-e6dbc5f9bdcd","type":"Finding","dc:description":"Expression of the D76N mutant KCNE1 protein in the model resulted in significant delay to repolarization of the myocytes, leading to prolonged QT interval in surface ECGs following myocardial infection in animals.  Because this was done in the presence of endogenous normal KCNE1, this was considered to be a dominant negative phenotype. However there is no indication in the paper of the relative levels of + to mutant KCNE1 protein, so not clear if this is truly dom neg.  Even overexpression of the normal KCNE1 delays repolarization, so this may not be such a great model.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11320260","rdfs:label":"Hoppe et al guinea pig model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/58a123aa-396a-4101-9493-08d20dd0f1e0","type":"EvidenceLine","dc:description":"Lower score because this variant is associated with acquired LQT following challenge.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a87194d-d6f8-4b41-a200-7af5c531f3f7","type":"Finding","dc:description":"The transgenic rabbit carrying the KCNE1 mutant gene was susceptible to acquired prolongation of the QT interval following challenge using thiopental-anaesthetized rabbits exposed to dofetilide (a channel blocker).  The animals then exhibited TdP at significantly higher levels and for longer times than non-transgenic animals.  Conclusion in the paper is that this model system shows reduced repolarization reserves, but no baseline phenotype, but show susceptibility to arrythmias on repolarization stress- model of the \"silent\" or acquired LQT in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27076034","rdfs:label":"Rabbit model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e2e2edb-645a-4c91-aa3c-aeefbbcfeb06_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d666d34-ed31-40a4-8abd-c07cadfcc26d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","rdfs:label":"K1754 I-1","detectionMethod":"SSCP analyses for KCNE1 analysis","phenotypes":"obo:HP_0005184","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2e2e2edb-645a-4c91-aa3c-aeefbbcfeb06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","allele":{"id":"https://genegraph.clinicalgenome.org/r/11385b2b-f304-41f1-b679-db0279e6ac8b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.221C>T (p.Ser74Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256871"}}}}],"specifiedBy":"GeneValidityUncategorizedProbandCriteria"},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abfb2c7c-de79-4b9b-9e70-35978b13f02f_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29625280","rdfs:label":"Family 1 Lane et al","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/abfb2c7c-de79-4b9b-9e70-35978b13f02f","type":"Family","rdfs:label":"Family 1 Lane et al"},"meetsInclusionCriteria":true,"phenotype":{"id":"obo:HP_0001657"},"phenotypePositiveAllelePositive":3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3ef03534-0eba-4310-8167-8d75fc756cf3_family_segregation","type":"FamilyCosegregation","dc:description":"This paper is included because it is a demonstration that, while KCNE1 is associated with JLNS when both copies are mutated, in this family, neither parent (each of whom carried one of the KCNE1 variants) was affected with prolonged QT interval or any clinical phenotype. Therefore, these variants appear to be clinically relevant in the homozygous or compound heterozygous state, but little evidence for clinical impact of heterozygous findings.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354783","rdfs:label":"JNLS family Schulze-Bahr","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/3ef03534-0eba-4310-8167-8d75fc756cf3","type":"Family","rdfs:label":"JNLS family Schulze-Bahr"},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0000399"},{"id":"obo:HP_0001657"}],"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/1e4ef723-43d3-4b29-b6a8-ad35412312e6_family_segregation","type":"FamilyCosegregation","dc:description":"Too little information on rest of family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29625280","rdfs:label":"Family 2 Lane","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/1e4ef723-43d3-4b29-b6a8-ad35412312e6","type":"Family","rdfs:label":"Family 2 Lane"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0001657"},"phenotypePositiveAllelePositive":2},{"id":"https://genegraph.clinicalgenome.org/r/147658e7-af00-4c61-98ea-2513d5fa0356_family_segregation","type":"FamilyCosegregation","dc:description":"In this paper, the proband had JLNS, and was homozygous for the D76N variant.  Her mother and a half sister were both heterozygous for this variant, and the paper claims they both had a history of syncope, seizures, partial hearing loss and/or prolonged QT interval. However, no other testing was done in the mother and half sister to rule out the contribution of other genes, and LQT itself is not normally associated with hearing loss.  No details of the cardiac phenotype in the heterozygous carriers was shown. It is unclear whether the phenotype described is due to KCNE1 D76N variant alone.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9445165","rdfs:label":"Duggal et al","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/147658e7-af00-4c61-98ea-2513d5fa0356","type":"Family","rdfs:label":"Duggal et al"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0000399"},"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/3ed78081-3cee-4a3a-9558-efe75beb011a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14499862","rdfs:label":"Chinese family","family":{"id":"https://genegraph.clinicalgenome.org/r/3ed78081-3cee-4a3a-9558-efe75beb011a","type":"Family","rdfs:label":"Chinese family","member":{"id":"https://genegraph.clinicalgenome.org/r/fd9032cf-c602-4713-ba6c-b6c9090fee44","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14499862","rdfs:label":"II:4","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f5e7062-cd2d-49f3-b6bf-af14d9109940_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14499862","allele":{"id":"https://genegraph.clinicalgenome.org/r/f62a9575-2e1e-47a6-9360-9ecac7e6d970","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.154G>A (p.Gly52Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA331920"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Of all 26 family members, six individuals had prolonged qt\nintervals (qtc.0.44 s) on ECG, four of them suffered from recurrent syncope, triggered by exercise or emotional stress, and another case (i-1) experienced sudden death 22 years ago (fig. 2). the proband II-4 first experienced her episode at age 16, thereafter two to three times every year, most episodes were triggered by exercise or emotional stress, sometimes accompanied by a low serum calcium level. she was diagnosed as LQTS (QTc=0,60 s at rest) and has\nbeen effectively treated with and b-blockers since 1997.","phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fd9032cf-c602-4713-ba6c-b6c9090fee44"},"publishedLodScore":2.11}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/93398e78-0315-4160-92b5-a548fd28eb21_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4522015-ca74-4e3b-a02f-f4d2415db4d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","rdfs:label":"K1754 II3","detectionMethod":"SSCP analyses for KCNE1 analysis","phenotypes":"obo:HP_0005184","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/93398e78-0315-4160-92b5-a548fd28eb21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","allele":{"id":"https://genegraph.clinicalgenome.org/r/11385b2b-f304-41f1-b679-db0279e6ac8b"}}}],"specifiedBy":"GeneValidityUncategorizedProbandCriteria"},{"id":"https://genegraph.clinicalgenome.org/r/957550ae-d91c-49e7-be7c-ff5a13faa3ff_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ed3e00e-f585-4d9a-a768-388c3c56e455_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozigosity","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8eeeb467-ef4f-4a3d-a63c-ddaa04b27d9a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155735","rdfs:label":"patient KCNE1, double mutations","phenotypeFreeText":"The patient was described as LQTS. No records are available.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3ed3e00e-f585-4d9a-a768-388c3c56e455_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155735","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e4f964ea-cdcd-4de0-9426-bc1cf6222e32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.242A>G (p.Tyr81Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA331950"}},{"id":"https://genegraph.clinicalgenome.org/r/1b12120c-71f9-47b0-93e2-d5b950b96dcb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.210G>C (p.Lys70Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA331945"}}]}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a150cc87-e3c6-40ad-bcdf-5b7cc34cea96_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e980a23-dff7-4b31-8fc4-3e74b7e9c853","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17341399","rdfs:label":"Proband 2 Ohno et al","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":19,"detectionMethod":"DHPLC across LQT genes and Sanger for variant amplicons","firstTestingMethod":"High resolution melting","phenotypes":"obo:HP_0001279","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a150cc87-e3c6-40ad-bcdf-5b7cc34cea96_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17341399","allele":{"id":"https://genegraph.clinicalgenome.org/r/6382fab5-fab2-4f80-af08-b77d1447c318","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.292C>T (p.Arg98Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA199783"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9fd7e588-c997-4f96-bc95-ea45db75383c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"D76N is too common in population to be a LQTS disease variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/323a895f-c9d4-4488-bd06-ede9a3343823","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","rdfs:label":"K1789","detectionMethod":"SSCP analyses for KCNE1 analysis","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9fd7e588-c997-4f96-bc95-ea45db75383c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9e4d0b7-311b-4c75-a604-2276a56631b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.226G>A (p.Asp76Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256867"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5e7cf82f-4641-4621-983c-769733740dbc_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bd29dbc-9217-4e58-9e47-ff45fe3a841f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21712262","rdfs:label":"Nof et al proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"detectionMethod":"Sequencing of KCNQ1, SCN5A, KCNH2, KCNE1, KCNE2 was performed, including intron/exon borders.","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0005184","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5e7cf82f-4641-4621-983c-769733740dbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21712262","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b351e48-e8fa-47af-b508-206f2c42b6c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA123130"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b706a72d-5ef5-4e67-b072-ec40acfa1a95_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9ca4c96-c246-4f44-8fdc-aceecd6bcdcc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17341399","rdfs:label":"Proband 1 Ohno et al","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":63,"detectionMethod":"DHPLC analysis of common LQT genes, followed by Sanger of amplicons with variant patterns","firstTestingMethod":"High resolution melting","phenotypes":"obo:HP_0005184","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b706a72d-5ef5-4e67-b072-ec40acfa1a95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17341399","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f2c3234-9202-474f-92f9-4c53c3b0c84d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000219.6(KCNE1):c.23C>T (p.Ala8Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/132670"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9f5e7062-cd2d-49f3-b6bf-af14d9109940_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd9032cf-c602-4713-ba6c-b6c9090fee44"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/034115a4-b4f3-49f9-a52c-508ecd722ca2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2677d925-81a7-4a3d-86a6-d574caff125a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","rdfs:label":"K1754 II-2","detectionMethod":"SSCP analyses for KCNE1 analysis","phenotypes":"obo:HP_0005184","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/034115a4-b4f3-49f9-a52c-508ecd722ca2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9354802","allele":{"id":"https://genegraph.clinicalgenome.org/r/11385b2b-f304-41f1-b679-db0279e6ac8b"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.6}],"evidenceStrength":"Limited","sequence":1845,"specifiedBy":"GeneValidityCriteria8","strengthScore":8.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/3-ncbdY2jSA","type":"GeneValidityProposition","disease":"obo:MONDO_0013372","gene":"hgnc:6240","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_957550ae-d91c-49e7-be7c-ff5a13faa3ff-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}